Project Grant HT94252310589
Award Date
8/1/23
Completion Date
7/31/27
Dollars Obligated
$5.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
The Defense Health Agency awarded a $498,896 Project Grant through the Military Medical Research and Development program (CFDA 12.420) to The Schepens Eye Research Institute, Inc. in Boston, MA. The grant supports a 2-year research project investigating the use of noninvasive transpalpebral electrical stimulation as a therapy for combat-related corneal trauma. As an experienced performer of prior federal grants from agencies like the NIH, DoD, and Army, the non-profit Schepens Eye Research...
The Defense Health Agency awarded a $1,466,706 Project Grant to The Schepens Eye Research Institute, Inc. under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective September 1, 2025 through August 31, 2028, will fund research on "Topical Oxygen for Pan-Ocular Protection (TOPP) Against Severe Chemical Injury". The Schepens Eye Research Institute, a non-profit organization affiliated with Harvard Medical School, will conduct preclinical and...
This $1,473,430 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports The Johns Hopkins University's research on pluripotent stem cell-derived corneal endothelial cells for the treatment of combat laser-induced corneal edema and vision restoration. Spanning from September 1, 2024 to August 31, 2027, this award will enable Johns Hopkins to conduct innovative biomedical research to develop new treatments for military...
This $999,741.00 Project Grant was awarded on June 15, 2023 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research by The Johns Hopkins University to develop early, intermediate, and late retinal biomarkers for assessing neuroprotection following acute optic neuritis. This research provides insights and exploration of the clinical trial for the investigational drug RENEW (opicinumab) in acute optic neuritis. As a...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,477,500 Project Grant to The Schepens Eye Research Institute, Inc., a non-profit organization affiliated with Harvard Medical School and Massachusetts Eye and Ear. The 3-year grant, awarded on September 1, 2023, will fund research on "Topical Calcitonin Gene-Related Peptide for Corneal Injury Prevention and Regeneration." The Schepens Eye Research Institute, which has...
The Schepens Eye Research Institute, Inc. was awarded a $1,477,390.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on June 15, 2023, will fund research to investigate the role of the Rho-kinase pathway in proliferative vitreoretinopathy, a serious eye condition, over a 3-year period ending on June 14, 2026. As a non-profit organization affiliated with Harvard Medical School and Massachusetts Eye and...
The Schepens Eye Research Institute, Inc. was awarded a $1,475,676 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2025 to develop concomitant topical treatments for pain and inflammation resulting from ocular injuries. The Military Medical Research and Development program supports biomedical research that transforms military and public health...
The Johns Hopkins University was awarded a $974,999.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, spanning August 1, 2023 to July 31, 2026, will support research to engineer an effective combination therapy of car T cells and regulatory T cells to control rejection of vascularized composite allografts. This research aims to develop medical solutions for the battlefield and transform healthcare for...
The Department of Defense's Defense Health Agency awarded a $820,833 Project Grant to The Schepens Eye Research Institute, Inc., a non-profit research organization affiliated with Harvard Medical School and Massachusetts Eye and Ear. The grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports a research project to "Identify the Liver Microenvironment that Drives Uveal Melanoma Metastasis and Immunity." The 3-year award, effective from...
This $426,400 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at the University of Chicago to conduct nanoscale structural and molecular mapping of the optic nervous system following ocular blast. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing understanding of the impact of ocular blast injuries on the nervous system. The award...